Figure 8.
Effect of NCS and PTX treatments in the Wnt/β-Catenin signaling pathway in MDA-MB-231 cells. β-Catenin, total- and phosphorylated-GSK3-β protein levels expression levels after PTX and NCS treatment, both alone and in combination (1:2 ratio), were determined. (A–C) Representative β-Catenin and GSK3-β protein levels after drug treatments. The β-actin protein expression level was used as a loading control. (B–D) Graphs represent the quantification band intensity signal referred to β-actin expression, represented as mean ± SEM of three independent experiments. Statistic t-test analysis of NCS and combined therapy was performed in comparison with control non-treated cells (black asterisks, ** p < 0.01, *** p < 0.001 and **** p < 0.0001) as well as with PTX treatment (blue asterisks, * p < 0.05 and ** p < 0.01).